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Abstract: Flow chemistry is considered to be a versatile and 
complementary methodology for the preparation of valuable organic 
compounds. We describe a straightforward approach for the synthesis 
of iodonium trifluoroacetates through the direct oxidation of 
iodoarenes in a simple flow reactor using an Oxone-filled cartridge. 
Optimization has been carried out using the Nelder-Mead algorithm. 
The procedure allows a wide range of iodonium salts to be prepared 
from simple starting materials. 
Introduction 
In last decades, hypervalent iodine compounds have found wide 
application as mild, efficient and environmentally friendly reagents 
in the modern toolbox of synthesis.[1] In particular, diaryliodonium 
salts have become essential instruments for arylation of different 
nucleophiles with or without metal catalysts.[ 2 ] Moreover, 
iodonium salts are found as reagents for the surface modification 
of carbon materials and noble metals.[3] 
Traditional procedures for the preparation of iodonium salts 
include the reaction of electrophilic iodine(III) species with 
electron-rich arenes.[4] Nowadays, the preliminary stage of the 
preparation of iodanes can be excluded and reactive iodine(III) 
species can be generated in situ. Such procedures have been 
investigated by Olofsson and co-workers[ 5 ] and successfully 
applied for the preparation of diaryliodonium tosylates, triflates 
and tetrafluoroborates.[6] Common oxidants for this reaction are 
K2S2O8, NaBO3, AcOOH and H2O2•urea.[7] Nevertheless, one of 
the most used oxidants for the preparation of iodonium salts is 
meta-chloroperbenzoic acid (mCPBA).[8] Recently, we reported 
other methods for the preparation of iodonium salts utilizing 
Oxone® as a cheap and alternative oxidant to mCPBA.[9] 
However, the known approaches for the preparation of iodonium 
salts do not align with the modern requirements on industrial 
processes. For instance, mCPBA is considered to be a hazardous 
reagent requiring specific operation and storage conditions[10] as 
well as the disposal of mCPBA-containing by-products. The 
preparation of iodonium trifluoroacetates through oxidation with 
Oxone is accompanied by a long reaction time.[9b] Therefore, the 
development of novel approaches for the preparation of iodonium 
salts is required for further simplification of the synthetic protocols. 
Flow chemistry is considered to be a straightforward method for 
the synthesis of various organic compounds and intermediates. 
Flow methodology provides a range of advantages over batch 
protocols, such as easy scale-up and optimization, effective 
mass- and energy transfer, reduction of waste and reaction time, 
safe in situ generation of toxic or hazardous compounds.[ 11 ] 
Moreover, flow methodology allows an easy use of optimization 
algorithms in manual or automatic mode, which improve the fast 
search for optimal reaction conditions.[12] The flow synthesis of 
hypervalent iodine compounds is little explored and only a few 
contributions can be found in the literature. Noël and coauthors 
developed a synthesis of diaryliodonium salts in flow with mCPBA 
as oxidant[13] while we reported the use of electricity as a reagent 
for the synthesis of iodine(III) reagents.[ 14 ] Nevertheless, the 
method proposed by Noël uses mCPBA with the aforementioned 
disadvantages. The electrochemical synthesis is free from 
reagent waste but allows the synthesis of diaryliodonium salts 
only from electron-rich substrates (Scheme 1). 
 
 
Scheme 1. Flow synthesis of diaryliodonium salts. 
Herein we report on the development of a flow synthesis of 
diaryliodonium trifluoroacetates using the Oxone® as the oxidant. 
Reaction conditions have been optimized using the Nelder-Mead 
algorithm for the synthesis of [bis(trifluoroacetoxy)iodo]benzene 
in flow and the subsequent reaction with arenes and arylboronic 
acids for the preparation of diaryliodonium salts.  
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Preliminary studies began with the preparation of 
[bis(trifluoroacetoxy)iodo]benzene under flow conditions based 
on our previous findings.[15] As reported earlier, Oxone® can be 
used as an effective oxidant for the preparation of iodine(III) 
derivatives and appropriate diaryliodonium trifluoroacetates. We 
proposed that a simple cartridge filled by powdered Oxone® can 
be the key part of the flow setup for the synthesis of iodine(III) 
derivatives. The flow setup is shown in Scheme 2 and proceeds 
by pumping a 0.1 M solution of iodobenzene 1a in 
dichloromethane containing 10% trifluoroacetic acid (TFA) 
through the Oxone® cartridge. 
 
Scheme 2. Flow synthesis of [bis(trifluoroacetoxy)iodo]benzene 2a. 
Different factors affect the yield of product and the reaction rate.[16]  
For the proposed setup, the concentration of reagents, the 
residence time and flow rate are the most important for the flow 
process. Even the optimization of a synthetic procedure with few 
variables can be performed by the Nelder-Mead Simplex method, 
its efficiency for flow protocols has been demonstrated 
previously.[ 17 ] We investigated the residence time, the 
concentration of iodobenzene, and the concentration of TFA. The 
results of the optimization are graphically shown in Figure 1, 
details are in Table S1 (supporting information). The amount of 
Oxone has been constant for the all experiments, the reaction 
time varied between 15 and 28.3 minutes, the amount of TFA 
between 7.7 and 17.4 vol% and the concentration of iodobenzene 
from 0.082 to 0.12 mmol mL–1. After the end of each reaction, the 
syringe with the mixture of reagents was replaced by a syringe 
with dichloromethane and the Oxone column was washed. Based 
on the selected parameters to optimize the yield of the product, 
we built the first simplex and run the reaction (reactions 1-4). After 
the new simplex has been generated, the reactions have been 
carried out under the new conditions until the termination criterion 
was reached (reactions 5-10). 
 
Figure 1. Graphic representation of the optimization of the synthesis of 2a. 
Best results were obtained in reactions 5 and 9 where 2a has 
been isolated in 90% yield but reactions 5 required an increased 
amount of CF3COOH without any influence on the yield of the 
desired product. The conditions of reaction 5 (0.09 M PhI, 13.9 
vol% TFA, 20 min) have then also been used to successfully 
prepare [bis(trifluoroacetoxy)iodo]toluene 2b in 86% yield and 
[bis(trifluoroacetoxy)iodo]-3-trifluoromethylbenzene 2c (59% 
yield).  
During the optimization we found that the amount of TFA is crucial 
for obtaining good yields of [bis(trifluoroacetoxy)iodo]benzene 2a. 
From the point of view of reducing the amount of trifluoroacetic 
acid, best results were obtained in the run 8. However, the 
residence time there increased significantly leading to a potential 
clogging of the Oxone cartridge, which was also observed when 
the cartridge was washed at the high flow rates. The reaction is 
most likely to proceed at the border between the liquid and solid 
phase. The interaction between Oxone® and TFA leads to the 
generation of peroxosulfuric acids and the amount of TFA 
determines the effective concentration of oxidant and increases 
its solubility.  
The optimization study has been carried out using a freshly filled 
Oxone® column for each experiment. One advantage of a 
reagent-filled column is the possibility for a repeated use. We 
therefore determined the number of runs for the one loading of 
Oxone® using the preparation of 2a as an example. The yield of 
2a did not changed during the first 3 runs (Figure 2). Clogging 
issues after the 3rd run was overcome by re-loading the column 
with the same Oxone® after drying and crushing allowing to retain 
the same efficiency (Figure 2). Re-loading after every 3rd run kept 
the efficiency to 11 runs, which corresponds to 1.4 equivalents of 
Oxone® for the oxidation of iodobenzene. As reloading is not ideal, 
we applied ultrasonication to the Oxone®-filled column after the 
3rd run which regenerates the column with same efficiency as the 
reloading procedure (Figure S2, supporting information). The 
dramatic decrease of yields after run 12 is associated with the 
depletion of potassium peroxymonosulfate in the solid phase.  
   
 
 
 
 
 
 
Figure 2. Repeated synthesis of 2a using the same Oxone cartridge. 
The optimized procedure for the preparation of iodine(III) 
derivatives was then extended to the synthesis of diaryliodonium 
salts by adding an arene as the second substrate. The 
intramolecular version of the process leads to dibenziodolium 
trifluoroacetate as an example for a cyclic iodonium salt[18 ] in 
almost quantitative yields as shown in Scheme 3. 
 
Scheme 3. Synthesis of dibenziodolium trifluoroacetate 4. 
Initial efforts to prepare acyclic diaryliodonium trifluoroacetates in 
flow were less successful when a mixture of mesitylene and 
iodobenzene were pumped through the Oxone cartridge. We 
observed the overoxidation of the mesitylene and the desired 
mesityl(phenyl)iodonium trifluoroacetate was obtained in only 
68% yield. Addition of the arene to the flow stream after the 
iodine(III) formation as shown in Scheme 4 is leading to higher 
yields. 
 
Scheme 4. Synthesis of iodonium salt 6a. 
Initial experiments have been carried out using mesitylene 5a as 
an arene and iodobenzene 1a. The addition of mesitylene in pure 
dichloromethane has been unsuccessful due to sedimentation of 
in the tubing reactor and clogging issues. Therefore, mesitylene 
was added in the same TFA-dichloromethane mixture, which 
allowed the isolation of mesityl(phenyl)iodonium trifluoroacetate 
6a in 90% yield. An increase of the reactor volume from 0.5 mL to 
1 mL did not change the yield of product 6a.  
The flow setup shown in Scheme 3 has then been applied to 
different arenes and iodoarenes leading to iodonium salts 
displayed in Figure 3. 
 
 
Figure 3. Synthesis of iodonium salts. aReaction conditions: 10 mL reagent 
mixture 1: 1 (0.9 mmol) and TFA (1.39 mL) in CH2Cl2, flow rate: 0.11 mL/min; 
11 ml reagent mixture 2: 5 (1.09 mmol), flow rate: 0.11 mL/min; Oxone-filled 
cartidge (5 g), room temperature; c1.04 mmol of arene was used; 
dPhenylboronic acid was used instead arene; e4-Trifluoromethoxyboronic acid 
was used instead of arene. 
Iodobenzene 1a smoothly reacted with electron-rich arenes 5a-d 
with the formation of desired iodonium salts 6a-d in good yields. 
Similar reactivities have been found in the reaction of methyl-
substituted iodoarenes 1b,1d, 1e and 1f with arenes 5a-d. The 
corresponding iodonium salts have been isolated in excellent 
yields. Only (3,5-dimethylphenyl)(2,4,6-trimethoxyphenyl) iodo-
nium trifluoroacetate 6m was accessible in only 50% yield, 
probably due to steric hindrance. We successfully applied the 
method to the preparation of iodonium salts from electron-poor 
iodoarenes 1c, 1g and 1h. In these cases, the yields of target 
compounds 6p-u have been slightly lower than for electron-rich 
arenes. This fact can be explained by the lower reactivity of 
appropriate iodoarenes in the oxidation process.[9b] Nevertheless, 
the flow approach provides a much shorter reaction time in 
comparison with batch procedures.[9a] We successfully prepared 
a range of 1,3,5-trimethoxyphenyl-substituted iodonium salts, 
   
 
 
 
 
 
which are considered to be most valuable compounds for further 
substitution.[8a,19] 
Finally, we investigated to obtain the iodonium salts from electron-
poor arenes such as benzene and toluene. The application of flow 
method did not change the reactivity of hypervalent iodine(III) 
species, and our efforts to involve benzene were unsuccessful. 
But the desired iodonium salts 6e and 6f could be obtained in the 
same setup using appropriate boronic acids as reagents in high 
yields. To the best our knowledge, these is the first example of 
the preparation of iodonium salts from boronic acids in a flow 
approach. 
Conclusions 
In conclusion, the synthesis of diaryliodonium trifluoroacetates in 
flow was demonstrated using an Oxone®-packed reactor. The 
Nelder-Mead algorithm for the optimization of the synthesis of 
bis(trifluoroacetoxy)iodobenzene enabled an increase of 
efficiency and speeded up the optimization process. Under 
optimized flow conditions a wide range of diaryliodonium 
trifluoroacetates including a cyclic derivative and some 
derivatives of [bis(trifluoroacetoxy)iodo]benzene with yields up to 
96% were accessible. The flow approach to the synthesis of 
diaryliodonium trifluoroacetates simplifies their formation with 
sensitive to strong oxidants electron-rich arenes with good yields. 
Successful examples of utilizing arylboronic acids to replace 
electron-poor arenes expands the applications of this method. 
 
Experimental Section 
General information 
All aromatic precursors, and other reagents and solvents were 
from commercial sources and used without further purification 
from freshly opened containers, NMR spectra were recorded at 
300, 400 and 500 MHz (1H NMR), 75, 100 MHz (13C NMR), 376 
and 471 MHz (19F NMR). Chemical shifts (δ) are reported in parts 
per million. Mass spectrometric measurements were performed 
by Laboratory of Physical–Chemical Analytical Methods of Tomsk 
State University or the EPSRC Mass Spectrometry Service 
Centre, Swansea University and ions were generated by the 
atmospheric pressure Electrospray Ionization (ESI). 
Preparation of the Oxone® cartridge: 
An Omnifit column 150 mm (6.6 mm ID) was packed with fine 
powdered Oxone (5.0 g, 8.1 mmol) occupying a volume of approx. 
2.2 ml, and the column was washed with CH2Cl2 (10 mL) at a flow 
rate of 0.5 mL/min. 
General Procedure for the synthesis of [bis(trifluoro-
acetoxy)iodo]benzene derivatives 2a-b 
Iodoarene (0.898 mmol) and TFA (1.39 mL) were dissolved in 
CH2Cl2 to achieve a total volume of 10 mL. The reagent mixture 
was pumped through the Oxone-filled cartridge using a syringe 
pump at a flow rate of 0.11 mL/min. After the end of the reagent 
addition, the syringe with the mixture of reagents was immediately 
replaced with a syringe containing CH2Cl2 (10 mL) and CH2Cl2 
was pumped with 0.11 mL/min flow rate for 30 min after which the 
flow rate was increased to 0.5 mL/min. The solvent was removed 
from the reaction mixture in vacuo and the residue was dried in 
vacuo (7 mbar) for 30 min. The crude mixture was dissolved in 
CH2Cl2 (5 mL) and any precipitate was removed through filtration. 
The solvent was removed in vacuo, the residue was washed with 
hexane (3 x 2 mL) and dried in vacuo. 
 [Bis(trifluoroacetoxy)iodo]benzene (2a) [15] 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL) and TFA 
(1.39 mL) according to the general procedure afforded 344-363mg (89-
94%) of [bis(trifluoroacetoxy)iodo]benzene 2a as a white crystalline solid; 
mp: 119-121 ºC (lit 118-120 ºC [15]). 1H NMR (400 MHz, CDCl3:CF3COOH 
25:1): δ 8.21 (d, J = 8.4 Hz, 2H), 7.76 (t, J = 7.6 Hz, 1H), 7.63 (t, J = 7.6 
Hz, 2H) ppm. 
1-Bis(trifluoroacetoxy)iodo-4-methylbenzene (2b) [20] 
The reaction of 4-iodotoluene 1b (0.898 mmol, 196 mg) and TFA (1.39 mL) 
according to the general procedure afforded 343 mg (86%) of 1-
[bis(trifluoroacetoxy)iodo]-4-methylbenzene 2b as a pale yellow crystalline 
solid; mp: 114-116 ºC (lit 113-115 ºC [20]). 1H NMR (400 MHz, 
CDCl3:CF3COOH 25:1): δ 8.10 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 
2.51 (s, 3H) ppm. 
1-[Bis(trifluoroacetoxy)iodo]-3-(trifluoromethyl)benzene (2c) [21] 
The reaction of 3-iodobenzotrifluoride 1c (0.898 mmol, 244 mg) and TFA 
(1.39 mL) according to the general procedure afforded 262 mg (59%) of 3-
[bis(trifluoroacetoxy)iodo]-1-(trifluoromethyl)benzene 2c as a white 
crystalline solid; mp: 96-98 ºC (lit 96-97 ºC [21]). 1H NMR (400 MHz, 
CDCl3:CF3COOH 25:1): δ 8.44 (s, 1H), 8.39 (d, J = 8.4 Hz, 1H), 8.00 (d, J 
= 7.6 Hz, 1H), 7.79 (t, J = 8.0 Hz, 1H) ppm. 19F NMR (376 MHz, 
CDCl3:CF3COOH 25:1): δ -62.98, -75.70 ppm. 
Synthesis of dibenzo[b,d]iodoniumtrifluoroacetate (4) 
2-Iodobiphenyl 3 (0.898 mmol, 251 mg) and TFA (1.39 mL) was dissolved 
in CH2Cl2 (5 mL) and the volume of mixture was brought to 10 mL by 
adding CH2Cl2. Then the reagent mixture was pumped through Oxone-
filled column with syringe pump. Flow rate was 0.11 mL/min. After the end 
of the reagent addition, the syringe with a mixture of reagents was 
immediately replaced with a syringe with CH2Cl2 (10 mL) and CH2Cl2 was 
pumped with 0.11 mL/min flow rate for 30 min. Then flow rate was 
increased to 0.5 mL/min and addition continued until the end of the CH2Cl2 
in the syringe. The solvent was removed from the resulting solution in 
vacuo and obtained residue was diluted with 5 mL of water. Product was 
extracted with CH2Cl2 (3 x 5 mL). The organic layer was dried over Na2SO4 
and solvent was removed in vacuo. Then diethyl ether (5 mL) was added 
to residue and formation of precipitate was observed. The suspension was 
stirred for 10 minutes and product was filtrated and washed with diethyl 
ether (5 mL) and hexane (2 x 5 mL). The product was dried in vacuo. 
Dibenzo[b,d]iodoniumtrifluoroacetate 4 was obtained in 96% yield (379 mg) 
as a beige crystalline solid; mp: 108-110 ºС. 1H NMR (400 MHz, CDCl3): δ 
8.46 (d, J = 8.4 Hz, 2H), 8.10 (dd, J = 8.0, 1.2 Hz, 2H), 7.76 (t, J = 8.0 Hz, 
2H), 7.61 (t, J = 8.4 Hz, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 161.3 (q, 
J = 38 Hz), 142.1, 131.4, 131.4, 131.0, 126.5, 122.0, 115.7 (q, J = 287 Hz) 
ppm. 19F NMR (376 MHz, CDCl3): δ -75.52 ppm. HRMS (ESI): m/z calcd 
for C12H8I+: 278.9665; found: 278.9665. 
   
 
 
 
 
 
General Procedure for the synthesis of diaryliodonium 
trifluoroacetates 6a-u 
Reagent mixture 1: Iodoarene 1a-h (0.898 mmol, 183 mg, 100 µL) 
and TFA (1.39 mL) were dissolved CH2Cl2 to achieve a total 
volume of 10 mL. Reagent mixture 2: Arene 5a-d (1.037-1.087 
mmol) or boronic acid 5e, f (1.087 mmol) and TFA (1.53 mL) were 
dissolved CH2Cl2 to achieve a total volume of 11 mL. 
Reagent mixture 1 was pumped through the Oxone-filled 
cartridge using a syringe pump at a flow rate of 0.11 mL/min. After 
15.5 minutes, reagent mixture 2 was started to pump with a 
second syringe pump with 0.11 mL/min. After the end of the 
reagent mixture 1 addition, the syringe with a mixture of reagents 
was immediately replaced with a syringe with CH2Cl2 (10 ml) and 
DC CH2Cl2 M was pumped with 0.11 ml/min until the end of the 
pumping reagent mixture 2. Then flow rate was increased to 0.22 
mL/min for 5 min, then and addition continued until the end of the 
CH2Cl2 in the syringe with 0.5 mL/min flow rate. Solvent was 
removed from the resulting solution in vacuo and the residue was 
diluted with water (5 mL). The product was extracted with CH2Cl2 
(3 x 5 mL). The organic layer was dried over Na2SO4 and the 
solvent was removed in vacuo. Then diethyl ether (5 mL) was 
added to the residue and a precipitate was formed, the 
suspension was stirred for 10 min, then the product was filtered 
off and washed with diethyl ether (5 mL) and hexane (10 mL). The 
obtained product was dried in vacuo. 
Mesityl(phenyl)iodonium trifluoroacetate (6a) 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL), mesitylene 
5a (1.087 mmol, 130 mg) and TFA (2.92 mL) according to the general 
procedure afforded 352 mg (90%) of mesityl(phenyl)iodonium 
trifluoroacetate 6a as a white crystalline solid; mp: 142-144 ºС (lit 137-138 
ºС [9a]). 1H NMR (400 MHz, CDCl3): δ 7.68 (d, J = 7.7 Hz, 2H), 7.49 (t, J = 
7.4 Hz, 1H), 7.37 (t, J = 7.8 Hz, 2H), 7.08 (s, 2H), 2.62 (s, 6H), 2.34 (s,3H) 
ppm. 13C NMR (100 MHz, CDCl3): δ161.0 (q, J = 37Hz, CF3COO-), 144.4, 
142.4, 132.9, 132.2, 131.7, 130.4, 121.3, 115.9 (q, J = 289Hz, CF3COO-), 
113.3, 27.1, 21.2 ppm. 19F NMR (376 MHz, CDCl3): δ -75.67 ppm. HRMS 
(ESI): m/z calcd for C15H16I+: 323.0297; found: 323.0299. 
Phenyl(thiophen-2-yl)iodonium trifluoroacetate (6b) 
The reaction of iodobenzene1a (0.898 mmol, 183 mg, 100 µL), 
thiophene5b(1.087 mmol, 91 mg) and TFA (2.92 mL) according to the 
general procedure afforded 242 mg (67%) of phenyl(thiophen-2-
yl)iodonium trifluoroacetate 6b as a beige crystalline solid; mp 152-154 ºС. 
1H NMR (400 MHz, CDCl3): δ 7.97 (d, J = 7.6 Hz, 2H), 7.72 (dd, J = 4.0, 
1.2 Hz, 1H), 7.59 (dd, J = 5.2, 1.2 Hz, 1H), 7.52 (t, J = 7.6 Hz, 1H), 7.39 (t, 
J = 7.6 Hz, 2H), 7.06 (dd, J = 5.2, 3.6 Hz, 1H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 160.9 (q, J = 38 Hz), 141.1, 137.4, 133.9, 132.5, 132.3, 130.2, 
118.3, 115.6 (q, J = 287Hz), 97.0 ppm. 19F NMR (376 MHz, CDCl3) δ -
75.30 ppm. HRMS (ESI): m/z calcd for C10H8IS+: 286.9391; found: 
286.9389. 
(4-Methoxyphenyl)(phenyl)iodonium trifluoroacetate (6c) 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL), anisole 5c 
(1.087 mmol, 117 mg) and TFA (2.92 mL) according to the general 
procedure afforded 247 mg (64%) of (4-methoxyphenyl)(phenyl)iodonium 
trifluoroacetate 6c as a beige crystalline solid; mp: 162-164 ºС (lit 137-138 
ºС [22]). 1H NMR (400 MHz, CDCl3): δ 7.90 (d, J = 7.6 Hz, 2H), 7.86 (d, J = 
8.8 Hz, 2H), 7.52 (t, J = 7.6 Hz, 1H), 7.38 (t, J = 7.6 Hz,2H), 6.89 (d, J = 
8.8 Hz, 2H), 3.81 (s,3H) ppm. 13C NMR (75 MHz, CDCl3): δ 162.9, 161.0 
(q, J = 37 Hz), 137.3, 134.3, 132.2, 132.1, 118.0,115.9 (q, J = 290 
Hz),115.4, 102.9, 55.8 ppm. 19F NMR (376 MHz, CDCl3): δ -75.32 ppm. 
HRMS (ESI): m/z calcd for C13H12IO+: 310.9933; found: 310.9930. 
Phenyl(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate (6d) 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 336 mg (77%) of 
phenyl(2,4,6-trimethoxyphenyl)iodoniumtrifluoroacetate 6d as a pale 
yellow crystalline solid; mp: 153-155 ºС (lit 160-165 ºС [8d]). 1H NMR (400 
MHz, CDCl3): δ 7.88 (d, J = 8.0 Hz, 2H), 7.46 (t, J = 7.4 Hz, 1H), 7.32 (t, J 
= 8.0 Hz, 2H), 6.16 (s, 2H), 3.86 (s, 6H), 3.85 (s, 3H) ppm. 13C NMR (100 
MHz, CDCl3): δ 166.8,161.7 (q, J = 34 Hz), 160.6, 133.9, 131.4, 131.3, 
117.0, 116.5 (q, J = 293 Hz), 91.5, 85.8, 56.9, 56.0 ppm. 19F NMR (376 
MHz, CDCl3): δ -75.31 ppm. HRMS (ESI): m/z calcd for C15H16IO3+: 
371.0139; found: 371.0139. 
Diphenyliodoniumtrifluoroacetate (6e) 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL), 
phenylboronic acid 5e (1.087 mmol, 133 mg) and TFA (2.92 mL) according 
to the general procedure afforded 261 mg (74%) of 
diphenyliodoniumtrifluoroacetate 6e as a white crystalline solid; mp: 202-
203 ºС (lit 197-198 ºС [7b]). 1H NMR (400 MHz, DMSO-d6): δ 8.25 (d, J = 
7.2 Hz, 4H), 7.66 (t, J = 7.6 Hz, 2H), 7.52 (t, J = 7.6 Hz, 4H) ppm. 13C NMR 
(100 MHz, DMSO-d6): δ 157.9 (q, J = 37 Hz), 135.2, 132.0, 131.7,117.3 (q, 
J = 295 Hz), 116.8 ppm. 19F NMR (376 MHz, DMSO-d6): δ -73.42 ppm. 
HRMS (ESI): m/z calcd for C12H10I+: 280.9822; found: 280.9822. 
Phenyl(4-(trifluoromethoxy)phenyl)iodoniumtrifluoroacetate (6f) 
The reaction of iodobenzene 1a (0.898 mmol, 183 mg, 100 µL), 4-
trifluoromethoxyphenylboronic acid 5f (1.087 mmol, 204 mg) and TFA 
(2.92 mL) according to the general procedure afforded 325 mg (76%) of 
phenyl(4-(trifluoromethoxy)phenyl)iodonium trifluoroacetate 6f as a white 
crystalline solid; mp: 192-194 ºС. 1H NMR (400 MHz, CDCl3): δ 8.01 – 7.96 
(m, 4H), 7.56 (t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 7.19 (d, J = 8.4 
Hz, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 161.5 (q, J = 36 Hz), 151.7, 
136.8, 135.1, 132.1, 132.0, 123.7,120.3 (q, J = 258 Hz), 117.5, 116.0 (q, J 
= 290 Hz), 113.9 ppm. 19F NMR (376 MHz, CDCl3): δ -57.84, -75.53 ppm. 
HRMS (ESI): m/z calcd for C13H9F3IO+: 364.9645; found: 364.9645. 
Mesityl(p-tolyl)iodoniumtrifluoroacetate (6g) 
The reaction of 4-iodotoluene 1b (0.898 mmol, 194 mg), mesitylene 5a 
(1.087 mmol, 130 mg) and TFA (2.92 mL) according to the general 
procedure afforded 380 mg (94%) of mesityl(p-tolyl)iodoniumtrifluoro-
acetate 6g as a white crystalline solid; mp: 155-156 ºС. 1H NMR (400 
MHz,CDCl3): δ 7.57 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 7.04 (s, 
2H), 2.62 (s, 6H), 2.33 (s, 3H), 2.32 (s, 3H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 161.2 (q, J = 36 Hz), 143.7, 142.1, 132.9, 132.7, 130.2, 123.1, 
166.8, 116.1 (q, J = 290 Hz), 111.5, 27.1, 21.4, 21.2 ppm. 19F NMR (376 
MHz, CDCl3): δ -75.52 ppm. HRMS (ESI): m/z calcd for C16H18I+: 337.0448; 
found: 337.0447. 
p-Tolyl(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate (6h) 
The reaction of 4-iodotoluene 1b (0.898 mmol, 196 mg), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 320 mg (72%) of p-tolyl(2,4,6-
trimethoxyphenyl)iodonium trifluoroacetate 6h as a beige crystalline solid; 
   
 
 
 
 
 
mp 161-163 ºС (lit 163-165 ºС [8d]). 1H NMR (400 MHz, CDCl3): δ 7.76 (d,J 
= 8.4 Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 6.15 (s, 2H), 3.86 (s, 6H), 3.84 (s, 
3H), 2.32 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 166.8, 161.0 (q, J = 
33 Hz), 160.5, 142.2, 134.0, 132.3, 116.2 (q, J = 290 Hz), 113.5, 91.5, 86.3, 
56.9, 56.0, 21.4 ppm. 19F NMR (376 MHz, CDCl3): δ -75.38 ppm. HRMS 
(ESI): m/z calcd for C16H18IO3+: 385.0295; found: 385.0295. 
Mesityl(m-tolyl)iodoniumtrifluoroacetate (6i) 
The reaction of 3-iodotoluene 1d (0.898 mmol, 196 mg), mesitylene 5a 
(1.087 mmol, 130 mg) and TFA (2.92 mL) according to the general 
procedure afforded 388 mg (96%) of mesityl(m-tolyl)iodoniumtrifluoro-
acetate 6i as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.53 (s, 1H), 7.39 
(d, J = 8.0 Hz, 1H), 7.34 (d, J = 7.2 Hz, 1H), 7.27 (t, J = 7.6 Hz, 1H), 7.11 
(s, 2H), 2.61 (s, 6H), 2.36 (s, 3H), 2.35 (s, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 160.8 (q, J = 36 Hz), 144.7, 143.3, 142.6, 133.4, 133.0, 132.1, 
130.6, 129.8, 119.9, 115.8 (q, J = 288 Hz), 112.0, 27.1, 21.5, 21.2 ppm. 
19F NMR (376 MHz, CDCl3): δ -75.80 ppm. HRMS (ESI): m/z calcd for 
C16H18I+: 337.0453; found: 337.0456. 
Thiophen-2-yl(m-tolyl)iodoniumtrifluoroacetate (6j) 
The reaction of 3-iodotoluene 1d (0.898 mmol, 196 mg), thiophene 5b 
(1.087 mmol, 91 mg) and TFA (2.92 mL) according to the general 
procedure afforded 308 mg (83%) of thiophen-2-yl(m-
tolyl)iodoniumtrifluoroacetate 6j as a yellow oil. 1H NMR (400 MHz, CDCl3): 
δ 7.79 – 7.78 (m, 2H), 7.74 (d, J = 8.0 Hz, 1H), 7.66 (dd, J = 5.2, 1.2 Hz, 
1H), 7.37 (d, J = 7.6 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.11 (dd, J = 5.6, 4.0 
Hz, 1H), 2.37 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 161.0(q, J = 38 
Hz), 143.1, 140.8, 137.1, 134.2, 133.3, 131.9, 130.9, 130.1, 118.5, 115.7(q, 
J = 287 Hz), 97.7, 21.5 ppm. 19F NMR (376 MHz, CDCl3): δ -75.72 ppm. 
HRMS (ESI): m/z calcd for C11H10SI+: 300.9548; found: 300.9548. 
(4-Methoxyphenyl)(m-tolyl)iodoniumtrifluoroacetate (6k) 
The reaction of 3-iodotoluene 1d (0.898 mmol, 196 mg), anisole 5c (1.087 
mmol, 117 mg) and TFA (2.92 mL) according to the general procedure 
afforded 365 mg (93%) of (4-methoxyphenyl)(m-
tolyl)iodoniumtrifluoroacetate 6k as a yellow oil. 1H NMR (500 MHz, CDCl3): 
δ 7.87 (d, J = 9.0 Hz, 2H), 7.72 (s, 1H), 7.67 (d, J = 8.5 Hz, 2H), 7.38 (d, J 
= 7.5 Hz, 1H), 7.31 (t, J = 8.0 Hz, 1H), 6.95 (d, J = 9.5 Hz, 2H), 3.83 (s, 
3H), 2.37 (s, 3H) ppm  13C NMR (75 MHz, CDCl3): δ 163.1, 160.3 (q, J = 
38 Hz), 143.2, 137.3, 134.7, 133.4, 132.0, 131.3, 118.2,115.8 (q, J = 288 
Hz), 114.5, 101.9, 55.9, 21.5 ppm. 19F NMR (471 MHz, CDCl3) δ -75.80 
ppm. HRMS (ESI): m/z calcd for C14H14OI+: 325.0089; found: 325.0094. 
(3,5-Dimethylphenyl)(4-methoxyphenyl)iodoniumtrifluoroacetate (6l) 
The reaction of 3,5-dimethyliodobenzene1e (0.898 mmol, 208 mg), anisole 
5c(1.087 mmol, 117 mg) and TFA (2.92 mL) according to the general 
procedure afforded 369 mg (88%) of (3,5-dimethylphenyl)(4-
methoxyphenyl)iodonium trifluoroacetate6las a beige crystalline solid; mp 
160-162 ºС. 1H NMR (400 MHz, CDCl3): δ 7.85 (d,J = 8.0 Hz, 2H), 7.51 (s, 
2H), 7.12 (s, 1H), 6.89 (d, J = 8.4 Hz, 2H), 3.81 (s, 3H), 2.29 (s, 6H) ppm. 
13C NMR (100 MHz, CDCl3) δ 162.4,161.3 (q, J = 36 Hz), 142.1, 136.8, 
133.7, 131.8, 117.6, 116.8, 116.1 (q,J = 290 Hz), 105.1, 55.7, 21.4 ppm. 
19F NMR (376 MHz, CDCl3): δ -75.50 ppm. HRMS (ESI): m/z calcd for 
C15H16IO+: 339.0240; found: 339.0240. 
(3,5-Dimethylphenyl)(2,4,6-trimethoxyphenyl)iodonium 
trifluoroacetate (6m) 
The reaction of 3,5-dimethyliodobenzene 1e (0.898 mmol, 208 mg), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 232 mg (50%) of (3,5-
dimethylphenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate 6m as a 
pale yellow crystalline solid; mp: 187-189 ºС. 1H NMR (400 MHz, CDCl3): 
δ 7.51 (s, 2H), 7.07 (s, 1H), 6.16 (s, 2H), 3.88 (s, 6H), 3.86 (s, 3H), 2.28 
(s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 166.8, 160.5, 160.5 (q, J = 35 
Hz), 141.7, 133.4, 131.5, 116.8, 115.9 (q, J = 289 Hz), 91.6, 86.1, 56.9, 
56.0, 21.4 ppm. 19F NMR (376 MHz, CDCl3): δ -75.79 ppm. HRMS (ESI): 
m/z calcd for C17H20IO3+: 399.0452; found: 399.0453. 
Mesityl(4-(trifluoromethoxy)phenyl)iodonium trifluoroacetate (6n) 
The reaction of 4-trifluorometoxyiodobenzene 1f (0.898 mmol, 257mg), 
mesitylene 5a (1.087 mmol, 130 mg) and TFA (2.92 mL) according to the 
general procedure afforded 364 mg (78%) of mesityl(4-
(trifluoromethoxy)phenyl)iodonium trifluoroacetate 6n as a white 
crystalline solid; mp: 167-169 ºС. 1H NMR (400 MHz, CDCl3): δ 7.73 (d, J 
= 9.2 Hz, 2H), 7.18 (d, J = 8.4 Hz, 2H), 7.07 (s, 2H), 2.62 (s, 6H), 2.33 (s, 
3H) ppm. 13C NMR (100 MHz, CDCl3): δ 161.7 (q, J = 35 Hz), 151.3(q, J = 
2 Hz), 143.9, 142.0, 134.7, 130.2, 123.8, 123.3, 120.3 (q, J = 258 Hz), 
116.2 (q, J = 291 Hz), 111.7, 27.1, 21.2 ppm. 19F NMR (376 MHz, CDCl3): 
δ -57.89, -75.47 ppm. HRMS (ESI): m/z calcd for C16H15F3IO+: 407.0114; 
found: 407.0113. 
(4-(Trifluoromethoxy)phenyl)(2,4,6-trimethoxyphenyl)iodonium 
trifluoroacetate (6o) 
The reaction of 4-trifluorometoxyiodobenzene 1f (0.898 mmol, 257mg), 
1,3,5-trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 338 mg (66%) of (4-
(trifluoromethoxy)phenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoro-
acetate 6o as a pale yellow crystalline solid; mp: 177-179 ºС. 1H NMR (400 
MHz, CDCl3): δ 7.95 (d, J = 8.8 Hz, 2H), 7.15 (d, J = 8.2 Hz, 2H), 6.17 (s, 
2H), 3.89 (s, 6H), 3.85 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 167.0, 
161.3 (q, J = 36 Hz), 160.5, 151.2 (q, J = 2 Hz), 135.8, 123.4, 120.3 (q, J 
= 258 Hz), 116.2 (q, J = 290 Hz), 113.6, 91.6, 86.8, 57.0, 56.0 ppm. 19F 
NMR (376 MHz, CDCl3): δ -57.84, -75.59 ppm. HRMS (ESI): m/z calcd for 
C16H15F3IO4+: 454.9962; found: 454.9963. 
(4-Chlorophenyl)(4-methoxyphenyl)iodoniumtrifluoroacetate (6p) 
The reaction of 4-chloroiodobenzene 1g (0.898 mmol, 214 mg), anisole 5c 
(1.087 mmol, 117 mg) and TFA (2.92 mL) according to the general 
procedure afforded 230 mg (56%) of (4-chlorophenyl)(4-
methoxyphenyl)iodonium trifluoroacetate 6p as a white crystalline solid; 
mp: 162-164 ºС. 1H NMR (400 MHz, CDCl3): δ 7.87 – 7.83 (m, 4H), 7.31 
(d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 3.81 (s, 3H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 162.6, 161.4(q, J = 36 Hz), 138.5, 137.1, 135.7, 131.9, 
117.7, 116.2(q, J = 291 Hz), 114.7, 105.7, 55.8 ppm. 19F NMR (376 MHz, 
CDCl3) δ -75.41 ppm. HRMS (ESI): m/z calcd for C13H11ClIO+: 344.9538; 
found: 344.9539. 
(4-Chlorophenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate 
(6q) 
The reaction of 4-chloroiodobenzene 1g (0.898 mmol, 214 mg), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 276 mg (59%) of (4-
chlorophenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate 6q as a 
pale yellow crystalline solid; mp: 167-169 ºС (lit 168-172 ºС [8d]). 1H NMR 
(400 MHz, CDCl3): δ 7.85 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.8 Hz, 2H), 6.18 
(s, 2H), 3.90 (s, 6H), 3.87 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 
   
 
 
 
 
 
166.9, 161.5 (q, J = 35 Hz),160.5, 137.9, 135.2, 131.5, 116.4 (q, J = 292 
Hz), 114.3, 91.5, 86.5, 56.9, 56.0 ppm. 19F NMR (376 MHz, CDCl3): δ -
75.49 ppm. HRMS (ESI): m/z calcd for C15H15ClIO3+: 404.9749; found: 
404.9748. 
(4-Fluorophenyl)(mesityl)iodonium trifluoroacetate (6r) 
The reaction of 4-fluoroiodobenzene 1h (0.898 mmol, 199 mg), mesitylene 
5a (1.087 mmol, 130 mg) and TFA (2.92 mL) according to the general 
procedure afforded 318 mg (78%) of (4-fluorophenyl) (mesityl)iodonium 
trifluoroacetate 6r as a white crystalline solid; mp: 146-148 ºС. 1H NMR 
(400 MHz, CDCl3): δ 7.69 (dd, J = 8.8, 4.8 Hz, 4H), 7.08 – 7.03 (m, 4H), 
2.62 (s, 6H), 2.32 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 164.3 (d, J 
= 252 Hz), 161.7 (q, J = 35 Hz), 143.8, 141.9, 135.3 (d, J = 9 Hz), 130.2, 
123.4, 119.3 (d, J = 23 Hz), 116.3 (q, J = 292 Hz), 108.6 (d, J = 3 Hz), 27.1, 
21.2 ppm. 19F NMR (376 MHz, CDCl3): δ -75.43, -107.25 ppm. HRMS 
(ESI): m/z calcd for C15H15FI+: 341.0197; found: 341.0196. 
(4-Fluorophenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate 
(6s) 
The reaction of 4-fluoroiodobenzene 1h (0.898 mmol, 199 mg), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 269 mg (60%) of (4-
fluorophenyl)(2,4,6-trimethoxyphenyl)iodonium trifluoroacetate 6s as a 
pale yellow crystalline solid; mp: 169-171 ºС (lit 165-169 ºС [8d]). 1H NMR 
(400 MHz, CDCl3): δ 7.90 (dd,J = 9.2, 5.2 Hz, 2H), 7.03 – 6.99 (m, 2H), 
6.15 (s, 2H), 3.87 (s, 6H), 3.84 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): 
δ 166.8, 164.3 (d, J = 252 Hz), 161.6 (q, J = 35 Hz), 160.5, 136.4 (d, J = 9 
Hz), 118.8 (d, J = 23 Hz), 116.4 (q, J = 292 Hz), 110.6 (d, J = 3 Hz), 91.5, 
86.6, 56.9, 56.0 ppm. 19F NMR (376 MHz, CDCl3): δ -75.40, -107.20 ppm. 
HRMS (ESI): m/z calcd for C15H15FIO3+: 389.0044; found: 389.0044. 
Thiophen-2-yl(3-(trifluoromethyl)phenyl)iodoniumtrifluoroacetate (6t) 
The reaction of 3-iodobenzotrifluoride 1c (0.898 mmol, 244 mg), thiophene 
5b (1.087 mmol, 91 mg) and TFA (2.92 mL) according to the general 
procedure afforded 253 mg (60%) of thiophen-2-yl(3-
(trifluoromethyl)phenyl)iodonium trifluoroacetate 6t as a grey crystalline 
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solid; mp: 102-104 ºС. 1H NMR (400 MHz, CDCl3): δ 8.20 – 8.19 (m, 2H), 
7.80 – 7.77 (m, 2H), 7.64 (dd, J = 5.2, 1.2 Hz, 1H), 7.54 (t, J = 8.4 Hz, 1H), 
7.10 (dd, J = 5.2, 4.0 Hz, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ 162.0 
(q, J = 36 Hz), 140.4, 137.1, 136.5, 133.6 (q, J = 34 Hz), 132.0, 130.6 (q, 
J = 4 Hz), 129.9, 128.5 (q, J = 4 Hz),122.3 (q, J = 272 Hz), 120.0, 116.0 
(q, J = 291 Hz), 102.1 ppm. 19F NMR (376 MHz, CDCl3): δ -62.89, -75.59 
ppm. HRMS (ESI): m/z calcd for C11H7F3IS+: 354.9260; found: 354.9259. 
(3-(Trifluoromethyl)phenyl)(2,4,6-
trimethoxyphenyl)iodoniumtrifluoroacetate (6u) 
The reaction of 3-iodobenzotrifluoride 1c (0.898 mmol, 196 mg), 1,3,5-
trimethoxybenzene 5d (1.037 mmol, 174 mg) and TFA (2.92 mL) 
according to the general procedure afforded 89 mg (18%) of (3-
(trifluoromethyl)phenyl)(2,4,6-trimethoxyphenyl)iodoniumtrifluoroacetate 
6u as a pale yellow crystalline solid; mp: 142-144 ºС. 1H NMR (400 MHz, 
CDCl3): δ 8.19 (d, J = 8.0 Hz, 1H), 8.14 (s, 1H), 7.71 (d, J = 8.0 Hz, 1H), 
7.47 (t, J = 8.0 Hz, 1H), 6.17 (s, 2H), 3.89 (s, 6H), 3.85 (s, 3H) ppm. 13C 
NMR (100 MHz, CDCl3): δ 167.0, 160.9 (q, J = 38 Hz), 160.5, 137.5,133.2 
(q, J = 33 Hz), 131.6, 130.7 (q, J = 4 Hz), 128.0 (q, J = 4 Hz),122.8 (q, J = 
272 Hz), 117.4, 116.0 (q, J = 289 Hz), 91.7, 87.3, 57.0, 56.0 ppm. 19F NMR 
(376 MHz, CDCl3): δ -62.86, -75.79 ppm. HRMS (ESI): m/z calcd for 
C16H15F3IO3+: 439.0012; found: 439.0013. 
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